Andrew is our EVP for Impact. He joined ieso in 2021 to help us harness our scientific breakthroughs and clinical learnings to transform global mental healthcare at scale.

Working alongside our Chief Scientific Officer, Andy Blackwell, he is responsible for forging strategic alliances with a wide range of organisations to collaborate on ground-breaking research and accelerate innovation and the adoption of new breakthroughs.

The significant advances being made in data science at ieso are set to transform the delivery of mental health and Andrew will be instrumental in amplifying our success to date.

As Head of Neuroscience and Mental Health at the Wellcome Trust, Dr Welchman led strategic initiatives for a £500m portfolio in cutting-edge brain science. He developed the multi-million-pound initiative in Mental Health Science that has become central to Wellcome’s ambitions for the next two decades.

As Professor of Neural Intelligence at the University of Cambridge, Andrew and his team combined advanced human brain imaging and AI to uncover how we perceive and understand the world around us. He is a Fellow of the Royal Society of Biology, has worked closely with several Royal Colleges (Royal College of Psychiatry; Royal College of Ophthalmology), and has been an advisor for large-scale international research efforts, collaborative partnerships (The India Alliance), The World Economic Forum and charities (BBC Children in Need).

“We know that poor mental health is an urgent and global problem – but we now need actions to meet the challenge. I have long admired ieso’s innovative data-driven approach to mental healthcare that shows how rigorous science improves treatment quality and delivers results for people suffering from mental health conditions. Tectonic shifts in technology mean we are primed to make quality care available for all. We are determined to drive change to reduce suffering so that millions of people around the globe lead flourishing lives.”